Epidermolysis Bullosa: Corrected iPS Stem Cell-Based Therapy – Video



(Part 5 of 6) Marius Wernig, MD, spoke at the "Spotlight on Disease Team Awards: Genetic Skin Disease," an educational event presented at the CIRM Governing Board meeting on February 4, 2010. Wernig is an assistant professor of pathology at the Institute for Stem Cell Biology and Regenerative Medicine in the Stanford School of Medicine. He is a co-principal investigator on the CIRM Disease Team that is developing a stem cell-based therapy for epidermolysis bullosa.

Visit link:
Epidermolysis Bullosa: Corrected iPS Stem Cell-Based Therapy - Video

Related Post